Mars 2021


When Immune System Favours Candida Albicans Growth
Keratinocytes Produce Their Own Glucocorticoids Which Control Skin Immune Homeostasis
Topical Tacrolimus Achieves 65% Success in Facial Vtiligo
Pruritus in Patients on Hemodialysis: Metabolomic Analysis Failed to Identify the Pruritogen
Hydroxychloroquine as a Systemic Treatment in Erosive Lichen Planus of the Vulva
Epidermal Cells in the Top Ten of the Turnover Rates in the Human Body

FOCUS (page 8)
He Global Burden of Atopic Dermatitis: a Second Rise From Middle Age
Criteria for Diagnosing Atopic Dermatitis in Infancy Are Still Imperfect
How Do Ophtalmologists Deal With Patients on Dupilumab
Metabolomics of Propyl-paraben Exposure Linked to Atopic Dermatitis Severity
A Step Forward: Abrocitinib, an Oral, Once-daily Janus Kinase 1 Selective Inhibitor, Effective and Well Tolerated in Atopic Dermatitis
New Treatments for Atopic Dermatitis Targeting: Beyond Il-4/il-13 Cytokines

SGDV / SSDV (page 14)
Preisausschreiben / Concours

Arbeitsgruppe für Dermatochirurgie – Groupe de travail de dermato-chirurgie (page 18)
Management von Hauttumoren: wie das Risiko von Lokalisie- rungsfehler vermindert werden kann
Prise en charge des tumeurs cutanées: comment diminuer le risque d’erreur de localisation

REPORTS (page 26)
Unraveling the COVID-toe enigma: a cutaneous sign of type I interferon-mediated resistance to SARS-CoV-2

Photo of the month (page 34)

Terminologie (page 37)
Morphaea / Morphée

Indistrie (page 38)
Neue Studie aus Schweden beweist erstmalig die Wirksamkeit der HPV-Impfung gegen Gebärmutterhalskrebs
Baricitinib als erster JAK-Inhibitor für die mittelschwere und schwere Form der atopischen Dermatitis zugelassen1